Isoquinoline alkaloid compound and preparation method and application thereof

By extracting and being separated from peppercorns and separating three alcoholic alkali compounds, it is confirmed that it is the inhibitor of the KV2.1 channel and the TRESK channel. Sexual suppression and analgesic effects.

CN115477650BActive Publication Date: 2025-01-24SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202110666488.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-06-16
Publication Date
2025-01-24
Estimated Expiration
2041-06-16

AI Technical Summary

Technical Problem

In the prior art, the mechanism of action of the active ingredients in peppercorns is unclear, and there is a lack of active molecules with novel structure, clear mechanism, and specific application types of diseases.

Method used

Extracted and separated from the peppercorns and separated the alcoholic alkali alkali compounds that have not been seen in the literature. And it has a suppressive effect on the TRESK potassium channel.

Benefits of technology

The selective suppression of the IK current and the KV2.1 channel is achieved, significantly inhibiting the electrical excitement of neurons, and showing the TRESK channel inhibitory activity that is stronger than the reported α-hydroxyl flower petechia, which has analgesic activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115477650B_ABST
    Figure CN115477650B_ABST
Patent Text Reader

Abstract

The present invention provides an isoquinoline alkaloid compound selected from the compounds shown in the following structural formula, and a preparation method and application thereof. The present invention first confirms that the isoquinoline alkaloid compound is a K Inhibitors of potassium current and background potassium current, especially inhibitors of Kv2.1 channels and TRESK channels, can be used to treat diseases such as stroke, arrhythmia, atrial fibrillation, diabetes, pain, respiratory depression, depression, etc.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Cited By

  • Application of quinazoline alkaloid HJ-70 in preparation of antiepileptic drugs

    CN122398808A